Evidence map›Paper›PMID 42176029›Full record

ArticleCellular and molecular life sciences : CMLS2026

Identification of the critical immune-related drivers shared by non-alcoholic fatty liver disease and osteoporosis.

Feifan Chang, Siliang Ge, Mingming Zhang, Fanfeng Wu, Fuming Cao, Jiang Liu, Mingxing Lei, Zhikang Guo, Wenbo Tang, Ming Chen and 5 more

Abstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Feifan ChangSchool of Medicine, Nankai University, Tianjin, China.
Siliang GeDepartment of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Mingming ZhangDepartment of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Fanfeng WuSchool of Medicine, Nankai University, Tianjin, China.
Fuming CaoDepartment of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Jiang LiuThe Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Mingxing LeiDepartment of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Zhikang GuoDepartment of Endocrinology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Wenbo TangFaculty of Hepato-Pancreato-Biliary Surgery, The Chinese PLA General Hospital, Beijing, China.
Ming ChenDepartment of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.
Liuyang ZhangDepartment of Comprehensive Treatment, The Second Medical Center of Chinese PLA General Hospital, Beijing, China.
Yezhou WangOrthopedic Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yi LiDepartment of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China. liyi301@126.com.
Pengbin YinSchool of Medicine, Nankai University, Tianjin, China. yinpengbin@gmail.com.ORCID http://orcid.org/0000-0002-5391-4477
Licheng ZhangDepartment of Orthopedics, Chinese PLA General Hospital, No. 28, Fuxing Road, Beijing, 100853, People's Republic of China.

Funding

National Natural Science Foundation of China 82202728National Natural Science Foundation of China 82472447Natural Science Foundation of Beijing Municipality 7254421Natural Science Foundation of Beijing Municipality L222086
6 · The paper itself

Abstract

backgroundNon-alcoholic fatty liver disease (NAFLD) and osteoporosis (OP) are two closely linked diseases, with immune cell dysregulation as a pivotal shared cause. However, the key drivers behind their pathogenesis remain poorly understood.

methodsMendelian randomization studies were performed to identify immune-related risk and protective factors for NAFLD and OP, focusing on 731 immune cell traits and 91 circulating inflammatory proteins. Transcriptomic datasets associated with NAFLD and OP were obtained from the Gene Expression Omnibus database, and their consistency and representativeness were assessed through differential gene expression and functional enrichment analyses. ImmuCellAI was then utilized to profile immunocyte abundance and immune-related hub genes were identified via a protein-protein interaction network of common differentially expressed genes in NAFLD and OP. Furthermore, the clinical relevance and main sources of immune-related hub genes were explored using UK Biobank data and single-cell RNA sequencing (scRNA-seq) data. Finally, a high-fat diet (HFD)-induced mouse model was established to validate the bioinformatics findings.

resultsWe identified 27 and 48 immune phenotypes that had causal effects on NAFLD and OP, respectively, showing similar immunopathogenic backgrounds. Differentially expressed genes maintained high consistency in each disease dataset and were significantly related to disease-specific functions and immune responses, such as inflammation and cytokine signaling. Subsequently, the dysregulation of T-helper (Th) cells was observed in both NAFLD and OP. Notably, three C-X-C motif chemokine ligand (CXCL) family genes, namely CXCL9, CXCL10, and CXCL11, were identified as hub genes, strongly correlating with Th cells. Furthermore, these CXCL family genes showed good diagnostic and predictive efficacy and were mainly expressed in myeloid cells. In the HFD-induced mouse model, the expression levels of these CXCL family hub genes were increased in both livers and bones, alongside elevated proportions of Th1, Th2, and Th17 cells.

conclusionOur research unveils that the infiltration of immune cells plays a pivotal role in NAFLD and OP, and the interaction between CXCL9/10/11 and Th cells may serve as a shared mechanism underlying the pathogenesis of NAFLD and OP. This finding enhances our understanding of comorbidity mechanisms and presents novel selections for biomarker and therapeutic targets.

Indexed as

Non-alcoholic Fatty Liver DiseaseOsteoporosisAnimalsChemokine CXCL10Chemokine CXCL11Chemokine CXCL9Diet, High-FatDisease Models, AnimalGene Expression ProfilingGene Expression RegulationGene Regulatory NetworksHumansLiverMaleMendelian Randomization AnalysisMiceChemokine CXCL10Chemokine CXCL11Chemokine CXCL9CXCL10 protein, humanCXCL11 protein, humanCXCL9 protein, humanbioinformaticsC-X-C motif chemokine ligand (CXCL)inflammationMendelian randomizationNon-alcoholic fatty liver disease (NAFLD)osteoporosis

Identifiers

PMID42176029
PMCPMC13376116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.